The co-existence of BRCA1 and TP53 loss-of-function (LOF) mutations, including in the primary UC tumor, also suggest that our patient’s tumor may have harbored a tandem duplicator phenotype that may have produced the FGFR3ex18-TACC3ex12 fusion in a subclonal population15,16. The gene discussed is TP53; the disease is neoplasm.